Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19

Am J Respir Crit Care Med. 2021 Jan 15;203(2):242-245. doi: 10.1164/rccm.202009-3386LE.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • COVID-19 / diagnosis
  • COVID-19 / immunology*
  • COVID-19 / mortality
  • COVID-19 / virology
  • COVID-19 Testing
  • Case-Control Studies
  • Critical Care
  • Critical Illness
  • Female
  • Germany / epidemiology
  • Graft Rejection / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunocompetence
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • SARS-CoV-2 / isolation & purification
  • SARS-CoV-2 / pathogenicity*

Substances

  • Immunosuppressive Agents